Fidelity Healthy Future Fund FAPHX

Medalist Rating as of | See Fidelity Investment Hub
  • NAV / 1-Day Return 14.90  /  −0.53 %
  • Total Assets 14.7M
  • Adj. Expense Ratio
    1.050%
  • Expense Ratio 1.050%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Large Growth
  • Investment Style Large Blend
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 0.78%
  • Turnover 80%

USD | NAV as of Sep 05, 2026 | 1-Day Return as of Sep 05, 2026, 12:11 AM GMT+0

Morningstar’s Analysis FAPHX

Will FAPHX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Fidelity Healthy Future holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FAPHX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 36.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

CVS Health Corp

5.03 717,852
Healthcare

UnitedHealth Group Inc

4.82 688,318
Healthcare

Johnson & Johnson

4.72 674,457
Healthcare

Procter & Gamble Co

3.93 560,910
Consumer Defensive

Tesla Inc

3.34 477,396
Consumer Cyclical

Welltower Inc

3.18 454,110
Real Estate

Unilever PLC

3.06 436,803
Consumer Defensive

Chubb Ltd

2.95 421,868
Financial Services

Hitachi Ltd

2.68 383,252
Industrials

Gilead Sciences Inc

2.46 351,307
Healthcare

Sponsor Center